LicianPro

INBX stock

Inhibrx Biosciences, Inc. (INBX) short interest & short volume · 43.5% of float short

Inhibrx Biosciences, Inc. official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

INBX short interest was little changed at 3.4M shares in the Oct 15, 2026 report (43.5% of float, 16.8 days to cover). Daily short volume averaged 63.4% of volume over the last 20 sessions, the 64th percentile of its own 20-day averages since Sep 23, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
3.4M
prior 3.4M
% of float
43.5%
float 7.9M
Days to cover
16.8
avg vol 203K
Change vs prior report
-0.5%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

% of float uses the current float for every report (no float was stored with older reports).

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 2)
81.4%
66K of 81K
20-day average
63.4%
prior 63.4%
Percentile vs own history
64th
233 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026

Short squeeze score (model)

Price since settlement: -10.4%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

INBX's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · INBX overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-0266,23581,35681.4%
2026-10-3099,836195,49451.1%
2026-10-2996,489155,20962.2%
2026-10-28366,836517,11670.9%
2026-10-2791,544147,23862.2%
2026-10-2662,40798,28463.5%
2026-10-2341,23659,13569.7%
2026-10-2282,836112,26073.8%
2026-10-2174,636101,07073.8%
2026-10-2031,94047,75566.9%

Healthcare peers with similar quant ratings

INBX is rated 1.19 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works

INBX short interest FAQ

What is INBX's short interest?

Inhibrx Biosciences, Inc. (INBX) had 3.4M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 43.5% of its 7.9M-share float.

How many days to cover does INBX have?

16.8 days: 3.4M shares short divided by an average daily volume of 203K for the Oct 15, 2026 period.

Is INBX short interest rising or falling?

INBX short interest was little changed (-0.5%) from 3.4M to 3.4M shares in the Oct 15, 2026 report.

Is INBX a short squeeze candidate?

Lician's squeeze watch scores INBX 65 out of 100 (elevated) from the Oct 15, 2026 report: short interest % of float 40/40, days to cover 25/25, change in short interest vs prior report 0/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of INBX daily volume is sold short?

63.4% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 64th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was INBX's latest FINRA short volume?

On Nov 2, 2026, cached FINRA short volume for Inhibrx Biosciences, Inc. (INBX) was 66,235 shares, 81.4% of 81,356 total volume.

How many INBX short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Inhibrx Biosciences, Inc. (INBX), from Oct 20, 2026 through Nov 2, 2026.

How did INBX short volume percent change from the prior cached session?

Cached FINRA short volume for Inhibrx Biosciences, Inc. (INBX) moved from 51.1% on Oct 30, 2026 to 81.4% on Nov 2, 2026, up 30.3 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.